SELLAS Life Sciences Group (SLS) Shares Outstanding (Weighted Average): 2011-2024
Historic Shares Outstanding (Weighted Average) for SELLAS Life Sciences Group (SLS) over the last 9 years, with Sep 2024 value amounting to $64.3 million.
- SELLAS Life Sciences Group's Shares Outstanding (Weighted Average) rose 100.65% to $64.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $64.3 million, marking a year-over-year increase of 100.65%. This contributed to the annual value of $70.4 million for FY2024, which is 119.52% up from last year.
- Latest data reveals that SELLAS Life Sciences Group reported Shares Outstanding (Weighted Average) of $64.3 million as of Q3 2024, which was down 0.00% from $64.3 million recorded in Q2 2024.
- Over the past 5 years, SELLAS Life Sciences Group's Shares Outstanding (Weighted Average) peaked at $64.3 million during Q2 2024, and registered a low of $6.7 million during Q1 2020.
- Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $28.3 million (2023), whereas its average is $34.9 million.
- Data for SELLAS Life Sciences Group's Shares Outstanding (Weighted Average) shows a peak YoY soared of 1,779.13% (in 2020) over the last 5 years.
- Over the past 5 years, SELLAS Life Sciences Group's Shares Outstanding (Weighted Average) (Quarterly) stood at $15.1 million in 2020, then increased by 5.44% to $15.9 million in 2021, then increased by 29.44% to $20.6 million in 2022, then soared by 55.73% to $32.1 million in 2023, then surged by 100.65% to $64.3 million in 2024.
- Its last three reported values are $64.3 million in Q3 2024, $64.3 million for Q2 2024, and $56.3 million during Q1 2024.